Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) FCF Margin (2016 - 2025)

Historic FCF Margin for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to 31.49%.

  • Apyx Medical's FCF Margin rose 84900.0% to 31.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.82%, marking a year-over-year increase of 170400.0%. This contributed to the annual value of 39.02% for FY2024, which is 279700.0% down from last year.
  • Apyx Medical's FCF Margin amounted to 31.49% in Q3 2025, which was up 84900.0% from 13.17% recorded in Q2 2025.
  • Over the past 5 years, Apyx Medical's FCF Margin peaked at 29.41% during Q3 2023, and registered a low of 62.24% during Q1 2024.
  • Moreover, its 5-year median value for FCF Margin was 31.91% (2021), whereas its average is 29.24%.
  • As far as peak fluctuations go, Apyx Medical's FCF Margin soared by 1240500bps in 2021, and later plummeted by -693900bps in 2024.
  • Apyx Medical's FCF Margin (Quarter) stood at 0.7% in 2021, then crashed by -5182bps to 37.05% in 2022, then skyrocketed by 58bps to 15.72% in 2023, then crashed by -42bps to 22.37% in 2024, then tumbled by -41bps to 31.49% in 2025.
  • Its FCF Margin was 31.49% in Q3 2025, compared to 13.17% in Q2 2025 and 8.03% in Q1 2025.